| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 29, 2022 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 436 | $19.93 | $8,689.48 | -0.2% | +17.0% | -37.0% | |
| Nov 29, 2022 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 307 | $19.93 | $6,118.51 | -0.3% | +17.0% | -37.0% | |
| Nov 29, 2022 | SINT Sintx Technologies, Inc. | Truetzel David W. | Director | Sell | 67 | $0.12 | $8.30 | -94.4% | -80.3% | -97.0% | |
| Nov 29, 2022 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 52 | $19.93 | $1,036.36 | -0.1% | +17.0% | -37.0% | |
| Nov 29, 2022 | HYPR Hyperfine, Inc. | Rothberg Jonathan M71 | Director, 10% Owner | Buy | 47,007 | $0.72 | $33,845.04 | +7.7% | +80.5% | +63.6% | |
| Nov 29, 2022 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 931 | $19.93 | $18,554.83 | -0.3% | +17.0% | -37.0% | |
| Nov 29, 2022 | ECOR Electrocore, Inc. | Errico Joseph P59 | Director | Buy | 25,000 | $0.33 | $8,252.50 | +1.0% | -28.3% | +15.8% | |
| Nov 29, 2022 | XAIR Beyond Air, Inc. | Carey Robert | Director | Buy | 30,000 | $5.75 | $172,491.00 | +1.9% | +4.9% | -72.4% | |
| Nov 29, 2022 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 18,800 | $22.13 | $416,128.60 | -0.6% | -2.5% | -59.4% | |
| Nov 29, 2022 | VERO Venus Concept Inc. | Natale Anthony77 | Director | Sell | 102,859 | $0.25 | $26,182.72 | -7.2% | -4.8% | -58.1% | |
| Nov 29, 2022 | RVP Retractable Technologies Inc | Leonard Braden Michael60 | 10% Owner | Sell | 252,400 | $2.00 | $505,524.08 | -3.2% | -6.1% | -43.9% | |
| Nov 29, 2022 | NXGL Nexgel, Inc. | Stein Nachum62 | Director | Buy | 7,100 | $1.39 | $9,867.60 | +0.4% | +22.3% | +54.0% | |
| Nov 28, 2022 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | President And CEO | Sell | 19,654 | $3.44 | $67,579.72 | -0.8% | -16.1% | -91.0% | |
| Nov 28, 2022 | CVRX Cvrx, Inc. | Verrastro Paul63 | Chief Mktg &Strat Officer | Sell | 4,600 | $11.94 | $54,931.02 | -32.9% | +1.5% | +71.6% | |
| Nov 25, 2022 | ECOR Electrocore, Inc. | Errico Joseph P | Director | Buy | 50,000 | $0.31 | $15,735.00 | +2.1% | -26.2% | +13.3% | |
| Nov 25, 2022 | RBOT Vicarious Surgical Inc. | Morris June89 | CLO, GC And Secretary | Sell | 2,500 | $3.69 | $9,222.50 | -0.8% | -20.2% | -90.0% | |
| Nov 25, 2022 | CTKB Cytek Biosciences, Inc. | Jeanmonod Patrik77 | Chief Financial Officer | Sell | 3,500 | $14.30 | $50,050.00 | -4.0% | -22.4% | -51.1% | |
| Nov 25, 2022 | VERO Venus Concept Inc. | Natale Anthony77 | Director | Sell | 154,284 | $0.28 | $42,829.24 | -6.1% | -22.9% | -62.6% | |
| Nov 23, 2022 | MLSS Milestone Scientific Inc. | Goldman Neal I79 | Director | Buy | 45,095 | $0.62 | $27,958.90 | +3.4% | +11.5% | +40.5% | |
| Nov 23, 2022 | ECOR Electrocore, Inc. | Errico Joseph P59 | Director | Buy | 100,000 | $0.31 | $31,050.00 | +4.5% | -22.0% | +23.5% | |
| Nov 23, 2022 | MLSS Milestone Scientific Inc. | Bernhard Leslie76 | Director | Sell | 14,358 | $0.64 | $9,189.12 | -8.3% | +11.5% | +40.5% | |
| Nov 23, 2022 | TMDX Transmedics Group, Inc. | Lovell Stephanie | Director | Sell | 10,557 | $58.80 | $620,721.50 | -100% | +8.2% | +17.5% | |
| Nov 23, 2022 | LNSR Lensar, Inc. | Winer Gary M53 | Director | Buy | 2,500 | $3.60 | $9,000.00 | +3.3% | -18.5% | -31.8% | |
| Nov 23, 2022 | BLFS Biolife Solutions Inc | De Greef Roderick74 | COO &President | Sell | 14,000 | $21.66 | $303,180.00 | -7.9% | -1.7% | -34.7% | |
| Nov 22, 2022 | UFPT Ufp Technologies Inc | Oberdorf Thomas | Director | Sell | 15,333 | $116.97 | $1,793,473.61 | -13.6% | -0.4% | +46.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.